Sponsor intelligence · OTHER
Clinical trials sponsored by
Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins.
Real, source-linked trial activity for Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins: 3 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Sep 24, 2026. Source-linked, daily-refreshed.
PHASE2 1N/A 1EARLY_PHASE1 1
Newest Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 1d ago | Study of Sarilumab With Immune Checkpoint Inhibitor Rechallenge in Pat | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 27d ago | Circulating Tumor DNA (ctDNA) in High Grade Upper Tract Urothelial Can | N/A | NOT_YET_RECRUITING | ↗ |
| 34d ago | Safety and Feasibility of First-line Avutometinib and Defactinib in Pa | EARLY_Ph 1 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.